Bosutinib (BOS) vs Imatinib (IM) for Newly Diagnosed Chronic Myeloid Leukemia (CML): Initial Results from the BFORE Trial

Saved in:
Bibliographic Details
Published in:Clinical lymphoma, myeloma and leukemia myeloma and leukemia, 2017-09, Vol.17, p.S316-S316
Main Authors: Cortes, Jorge, Gambacorti-Passerini, Carlo, Deininger, Michael, Mauro, Michael, Chuah, Charles, Kim, Dong Wook, Reilly, Laurence, Jeynes-Ellis, Alison, Leip, Eric, Bardy-Bouxin, Nathalie, Hochhaus, Andreas, Brümmendorf, Tim
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:2152-2650
2152-2669
DOI:10.1016/j.clml.2017.07.117